RxDoctor Payments Data

Bernhard Meyer, MD

Orthopaedic Surgery of the Spine · Houston, TXNPI 1225036429

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $207,135 of the $237,796 with a category attached, or 87.1%. Depuy Synthes Products, Inc. accounts for 88.1% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2020 at $119,460 and has fallen 97.1% since, to $3,510 in 2025.

$237,796in general payments, 2019–2025

Across 263 payments — averaging $904.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$209K
  • Medical Device Business Services, Inc.$8K
  • Johnson & Johnson$5K
  • Medtronic$3K
  • Globus Medical$3K
  • Cerapedics Inc.$2K
  • plus $8K from 26 others

What the payments were for

  • Royalty or licence$207,13587%
  • Consulting fees$9,8404%
  • Travel & lodging$3,3691%
  • Food & beverage$17,4177%
  • Education$360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$237,796 in reported general payments places this provider in the 85th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas

Medicare billing

Part B allowed, 2024
$183,188
Medicare patients
429
Services billed
1,237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium358$4,321
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen85$755
Gabapentin120$752
Celecoxib36$727
Mupirocin31$206
Acetaminophen-CodeineAcetaminophen With Codeine27$192
Methylprednisolone21$127
Meloxicam56$123
Cephalexin19$34
Tramadol Hcl20$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →